Effect of interfraction interval in hyperfractionated radiotherapy with or without concurrent chemotherapy for Stage III nonsmall cell lung cancer
- 15 January 1996
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 34 (2) , 303-308
- https://doi.org/10.1016/0360-3016(95)02158-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer.Journal of Clinical Oncology, 1995
- A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: An interim toxicity analysis of the first 100 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Are half-times of repair reliably shorter for tumors than for late normal-tissue effects?International Journal of Radiation Oncology*Biology*Physics, 1995
- Hyperfractionated radiation therapy (hfx rt) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: A phase II studyInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Radiotherapy of the rhabdomyosarcoma R1H of the rat: influence of the time interval between two daily fractions during hyperfractionated radiotherapyRadiotherapy and Oncology, 1994
- A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: Report of radiation therapy oncology group 84-07International Journal of Radiation Oncology*Biology*Physics, 1993
- Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma—Possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: Report of the radiation therapy oncology group protocol 8302International Journal of Radiation Oncology*Biology*Physics, 1993
- Astro plenary: Interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: Results from radiation therapy oncology group protocol 8313International Journal of Radiation Oncology*Biology*Physics, 1991
- Intervals between multiple fractions per day—Differences between early and late reactionsActa Oncologica, 1988
- Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (Preliminary report) by the radiation therapy oncology group (RTOG)International Journal of Radiation Oncology*Biology*Physics, 1987